Skip to Content

Aclidinium Bromide



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)

Treatment of COPD (chronic obstructive pulmonary disease)

Chemical Name

(3R)-3-{[hydroxydi(tiophen-2-yl)acetyl]oxy}-1-(3-phenoxypropyl)-1t⁵-azabicyclo[2.2.2]octan-1-ylium bromide (WHO)

Foreign Names

  • Aclidinii bromidum (Latin)
  • Aclidinin bromid (German)
  • Aclidinium, bromure d' (French)
  • Aclidinio, bromuro de (Spanish)

Generic Names

  • Aclidinium Bromide (OS: JAN)
  • 14115700 (IS)
  • LAS 34273 (IS)
  • LAS 34273 micronized (IS)
  • LAS W-330 (IS)
  • UNII-UQW7UF9N91 (IS)

Brand Names

  • Bretaris
    Almirall, Austria; Almirall, Spain; Almirall, Hungary; Almirall, Lithuania; Almirall, Poland; Almirall, Slovakia; Almirall Hermal, Germany; AstraZeneca, Slovenia; Berlin-Chemie, Croatia (Hrvatska)
  • Bretaris Genuair
    Guidotti, Italy; Industrias Farmaceuticals Almirall, Bosnia & Herzegowina; Industrias Farmaceuticas Almirall, Macedonia; Menarini, Belgium
  • Brimica (Aclidinium Bromide and Formoterol)
    Almirall, Poland; AstraZeneca, Slovenia; Berlin-Chemie, Croatia (Hrvatska)
  • Brimica Genuair (Aclidinium Bromide and Formoterol fumarate dihydrate)
    Berlin-Chemie, Germany
  • Duaklir (Aclidinium Bromide and Formoterol)
    Allmiral, United Kingdom; Almirall, Poland; AstraZeneca, Germany
  • Eklira
    Almirall, Austria; Almirall, Denmark; Almirall, Spain; Almirall, Iceland; Almirall, Lithuania; Almirall, Poland; Almirall, Slovakia; Almirall Hermal, Germany; AstraZeneca, Switzerland; AstraZeneca UK, United Kingdom
  • Eklira Genuair
    A. Menarini, Ireland; Almirall, Finland; Almirall, Italy; Almirall, Norway; Almirall, Sweden
  • Tudorza
    Almirall, Canada; Forest, United States


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.